Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ASX/DXB stock hub

ASX/DXB has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ASX/DXBis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

129.1M

Australian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

ASX/DXB

In the news

Latest news · ASX/DXB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 20.4P75 41.2

Trailing P/En/a

P25 14.2P50 19.2P75 35.1

ROE-594.5

P25 -118.7P50 -49.4P75 -1.2

ROIC-887.5

P25 -74.7P50 -33.5P75 0.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ASX/DXB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

180

Groups with data

Currency

AUD

Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Australia
Country code	AU
Employees	15
Enterprise value	AUD 90.6M
Exchange	Australian Securities Exchange
Financial currency	AUD
First seen	2026-05-10
Industry	Biotechnology
Isin	AU000000DXB7
Last refreshed	2026-05-10
Market cap	AUD 129.1M
Price	AUD 0.22
Price currency	AUD
Rev Per Employee	494,405.13x
Sector	Healthcare
Sic	2836
Symbol	asx/DXB
Website	https://dimerix.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-12.64%
EV Earnings	-5.56x
EV/FCF	7.93x
EV/Sales	12.22x
FCF yield	8.85%
P/B ratio	-76.78x
P/S ratio	17.41x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
FCF margin	154.08%
Gross margin	100%
Gross Profit	AUD 7.4M
Gross Profit Growth	32.74%
Gross Profit Growth Q	636.37%
Gross Profit Growth3 Y	163.04%
Gross Profit Growth5 Y	189%
Net Income	AUD -16.3M
Net Income Growth Years	1%
Pretax Margin	-543.4%
Profit Margin	-219.94%
Profit Per Employee	AUD -1.1M
ROA	-58.27
Roa5y	-43.38
ROCE	-77.77
ROE	-594.5
Roe5y	-126.2
ROIC	-887.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	5.08%
Cagr1y	-69.09%
Cagr3y	36.51%
Cagr5y	-3.01%
EPS Growth Years	2
Revenue Growth	1,219.93x
Revenue Growth Q	636.37x
Revenue Growth Quarters	3x
Revenue Growth Years	2x
Revenue Growth3 Y	163.04x
Revenue Growth5 Y	189x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	AUD 0.17
Assets	AUD 64.6M
Cash	AUD 38.5M
Current Assets	AUD 40.1M
Current Liabilities	AUD 12.7M
Debt	AUD 33,418
Debt FCF	AUD 0
Equity	AUD -1.7M
Liabilities	AUD 66.2M
Long Term Assets	AUD 24.4M
Long Term Liabilities	AUD 53.5M
Net Cash	AUD 38.5M
Net Cash By Market Cap	AUD 29.79
Net Cash Growth	83.48%
Net Debt FCF	AUD -3.37
Tangible Book Value	AUD -1.7M
Tangible Book Value Per Share	AUD -0
WACC	6.45

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.15
Net Working Capital	AUD -11M
Quick ratio	3.14
Working Capital	AUD 27.4M
Working Capital Turnover	AUD 0.33

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-10.57%
Dividend per share	AUD 0
Last Dividend	AUD 0.01

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	64.11%
1Y total return	-69.06%
200-day SMA	0.47
3Y total return	154.44%
50-day SMA	0.34
50-day SMA vs 200-day SMA	50under200
5Y total return	-14.19%
All Time High	0.79
All Time High Change	-72.61%
All Time High Date	2025-05-05
All Time Low	0.05
All Time Low Change	313.46%
All Time Low Date	2023-06-06
ATR	0.03
Beta	0.4
Beta1y	1.76
Beta2y	1.52
Ch YTD	-60.91
High	0.22
High52	0.72
High52 Date	2025-05-08
High52ch	-70.14%
Low	0.2
Low52	0.2
Low52 Date	2026-05-07
Low52ch	10.26%
Ma50ch	-36.65%
Price vs 200-day SMA	-54.03%
RSI	33.01
RSI Monthly	36.33
RSI Weekly	26.08
Sharpe ratio	-1.08x
Sortino ratio	-1.27
Total Return	-10.57%
Tr YTD	-60.91
Tr1m	-32.81%
Tr3m	-56.12%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	AUD -40.3M
Operating margin	-543.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	470,694,029%
Net Borrowing	-118,897
Shares Insiders	19.73%
Shares Institutions	2.3%
Shares Out	600,396,776
Shares Qo Q	6.04%
Shares Yo Y	10.57%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	AUD 10.5M
Average Volume	3,252,128.6x
Bv Per Share	-0
CAPEX	AUD -17,783
Ch10y	53.57
Ch1m	-32.81
Ch1y	-69.06
Ch3m	-56.12
Ch3y	150
Ch5y	-15.69
Ch6m	-54.74
Change	4.88%
Change From Open	7.5
Close	0.21
Days Gap	-2.44
Depreciation Amortization	12,777
Dollar Volume	494,333.8
Earnings Date	2026-05-26
EBIT	AUD -40.3M
EBITDA	AUD -40.3M
EPS	AUD -0.03
F Score	3
FCF	AUD 11.4M
FCF EV Yield	12.61x
FCF Per Share	AUD 0.02
Financing CF	6,376,483
Fiscal Year End	June
Income Tax	AUD -24M
Investing CF	-10,563
Is Primary Listing	1
Last Earnings Date	2026-02-24
Last Report Date	2025-12-31
Last Split Date	2017-10-23
Last Split Type	Reverse
Ma150	0.46
Ma150ch	-53.23%
Ma20	0.31
Ma20ch	-30.49%
Net CF	17,372,523
Next Earnings Date	2026-05-26
Open	0.2
P FCF Ratio	11.3
P OCF Ratio	11.28
Position In Range	75
Ppne	54,576
Price Date	2026-05-08
Relative Volume	0.71x
Revenue	7,416,077x
SBC By Revenue	12.12x
Share Based Comp	898,760
Tax By Revenue	-323.46x
Tr6m	-54.74%
Volume	2,299,227
Z Score	-0.89

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ASX/DXB pay a dividend?

Capital-return profile for this ticker.

Performance

ASX/DXB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ASX/DXB?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.3%

Share of float held by funds and institutions

Insider ownership

+19.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+10.6%

Negative means the company is buying back shares.

Technical

ASX/DXB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

33.0

Neutral momentum band

Price vs 200-day MA

-54.0%

50/200-day relationship not available

Beta (5Y)

0.40

Less volatile than the market

Sharpe ratio

-1.08

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ASX/DXB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current asx/DXB stock rating?

asx/DXB is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full asx/DXB analysis?

The full report lives at /stocks/asx/DXB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for asx/DXB?

The latest report frames asx/DXB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the asx/DXB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.